These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
775 related articles for article (PubMed ID: 25949228)
1. Fractionated stereotactic radiotherapy plus bevacizumab after response to bevacizumab plus irinotecan as a rescue treatment for high-grade gliomas. Conde-Moreno AJ; García-Gómez R; Albert-Antequera M; Almendros-Blanco P; De Las Peñas-Bataller R; González-Vidal V; López-Torrecilla JL; Ferrer-Albiach C Rep Pract Oncol Radiother; 2015; 20(3):231-8. PubMed ID: 25949228 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708 [TBL] [Abstract][Full Text] [Related]
3. Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review. Kulinich DP; Sheppard JP; Nguyen T; Kondajji AM; Unterberger A; Duong C; Enomoto A; Patel K; Yang I Acta Neurochir (Wien); 2021 Jul; 163(7):1921-1934. PubMed ID: 33796887 [TBL] [Abstract][Full Text] [Related]
4. Radiosurgery and Stereotactic Brain Radiotherapy with Systemic Therapy in Recurrent High-Grade Gliomas: Is It Feasible? Therapeutic Strategies in Recurrent High-Grade Gliomas. Gregucci F; Surgo A; Carbonara R; Laera L; Ciliberti MP; Gentile MA; Caliandro M; Sasso N; Bonaparte I; Fanelli V; Tortora R; Paulicelli E; Surico G; Lombardi G; Signorelli F; Fiorentino A J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013284 [TBL] [Abstract][Full Text] [Related]
5. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter? Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L; Glass J; Evans JJ; Andrews DW; Werner-Wasik M; Shi W J Neurooncol; 2018 Dec; 140(3):623-628. PubMed ID: 30182159 [TBL] [Abstract][Full Text] [Related]
6. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389 [TBL] [Abstract][Full Text] [Related]
7. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment. Shi W; Blomain ES; Siglin J; Palmer JD; Dan T; Wang Y; Werner-Wasik M; Glass J; Kim L; Bar Ad V; Bhamidipati D; Evans JJ; Judy K; Farrell CJ; Andrews DW J Neurooncol; 2018 Mar; 137(1):171-177. PubMed ID: 29235052 [TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary management of adult low grade gliomas. Mariş D; Nica D; Mohan D; Moisa H; Ciurea AV Chirurgia (Bucur); 2014; 109(5):590-9. PubMed ID: 25375042 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience. Guan Y; Xiong J; Pan M; Shi W; Li J; Zhu H; Gong X; Li C; Mei G; Liu X; Pan L; Dai J; Wang Y; Wang E; Wang X BMC Cancer; 2021 Feb; 21(1):123. PubMed ID: 33546642 [TBL] [Abstract][Full Text] [Related]
10. Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma. Lee YP; Jung HA; Lee MS; Choi JW; Kong DS; Seol HJ; Nam DH; Lee JI; Lee SH J Neurooncol; 2022 Feb; 156(3):541-549. PubMed ID: 35094201 [TBL] [Abstract][Full Text] [Related]
11. Bevacizumab-containing regimen in relapsed/progressed brain tumors: a single-institution experience. Schiavetti A; Varrasso G; Mollace MG; Dominici C; Ferrara E; Papoff P; Di Biasi C Childs Nerv Syst; 2019 Jun; 35(6):1007-1012. PubMed ID: 30903281 [TBL] [Abstract][Full Text] [Related]
12. FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan. Colavolpe C; Chinot O; Metellus P; Mancini J; Barrie M; Bequet-Boucard C; Tabouret E; Mundler O; Figarella-Branger D; Guedj E Neuro Oncol; 2012 May; 14(5):649-57. PubMed ID: 22379188 [TBL] [Abstract][Full Text] [Related]
13. Randomized prospective trial of fractionated stereotactic radiosurgery with chemotherapy versus chemotherapy alone for bevacizumab-resistant high-grade glioma. Bergman D; Modh A; Schultz L; Snyder J; Mikkelsen T; Shah M; Ryu S; Siddiqui MS; Walbert T J Neurooncol; 2020 Jun; 148(2):353-361. PubMed ID: 32444980 [TBL] [Abstract][Full Text] [Related]
14. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843 [TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic therapy for high-grade glioma. Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542 [TBL] [Abstract][Full Text] [Related]
16. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840 [TBL] [Abstract][Full Text] [Related]
18. Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme. Greer L; Pannullo SC; Smith AW; Taube S; Yondorf MZ; Parashar B; Trichter S; Nedialkova L; Sabbas A; Christos P; Wernicke AG Cureus; 2017 Jun; 9(6):e1388. PubMed ID: 28775928 [TBL] [Abstract][Full Text] [Related]
19. Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years. Ohno M; Miyakita Y; Takahashi M; Igaki H; Matsushita Y; Ichimura K; Narita Y Radiat Oncol; 2019 Nov; 14(1):200. PubMed ID: 31718669 [TBL] [Abstract][Full Text] [Related]
20. Surgery for Recurrent High-Grade Glioma After Treatment with Bevacizumab. Blumenthal DT; Kanner AA; Aizenstein O; Cagnano E; Greenberg A; Hershkovitz D; Ram Z; Bokstein F World Neurosurg; 2018 Feb; 110():e727-e737. PubMed ID: 29183864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]